For the attention of:Dr Fiona GodleeEditor in Chief of The BMJ
Dear Dr Godlee, in a recent article on The BMJ, Mohammed Razai et al "offer an overview of vaccine hesitancy and some approaches that clinicians and policymakers can adopt at the individual and community levels to help people make informed decisions about covid-19 vaccination".
Currently it appears the covid-19 vaccine products aren't claimed to prevent infection/transmission re SARS-CoV-2, they're purported to reduce the symptoms of the disease covid-19. (This is an important distinction, which I realised after publication of my BMJ rapid response last year, requesting clarification of whether these were really covid-19 vaccines…or SARS-CoV-2 vaccines? I question the status of the covid-19 'vaccines' and the quality of the 'immunity' they provide, and prefer to describe these products as covid-19 'injections'.)
But if people aren't at serious risk of covid-19, why should they be pressed to have covid-19 injections? This applies to most people, particularly children and young people, who are not greatly affected by SARS-CoV-2.
Why are people not at serious risk of covid being set up to have covid inje...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).